flucloxacillin 250mg powder for solution for injection or infusion
wockhardt uk limited - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 250 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin
flucloxacillin 500mg powder for solution for injection or infusion
wockhardt uk limited - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 500 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin
flucloxacillin 1g powder for solution for injection or infusion
wockhardt uk limited - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 1 gram(s) - beta-lactamase resistant penicillins; flucloxacillin
protamine sulphate leo pharma 1400 anti-heparin iu/ml solution for injection and infusion
leo pharma a/s - protamine sulphate - solution for injection/infusion - 1400 international unit(s)/millilitre - antidotes; protamine
angiox 250mg powder for concentrate for solution for infusion vials
the medicines company uk ltd - bivalirudin - powder for solution for infusion - 250mg
aciclovir 250mg/10ml concentrate for solution for infusion vials
pfizer ltd - aciclovir sodium - solution for infusion - 25mg/1ml
bivalirudin 250mg powder for concentrate for solution for infusion vials
accord-uk ltd - bivalirudin - powder for solution for infusion - 250mg
tambocor 10 mg/ml solution for injection or infusion
mylan ire healthcare limited - flecainide acetate - solution for injection/infusion - 10 milligram(s)/millilitre - antiarrhythmics, class ic; flecainide
brevibloc esmolol hydrochloride 2.5g/10ml injection
phebra pty ltd - esmolol hydrochloride, quantity: 250 mg/ml - injection, concentrated - excipient ingredients: propylene glycol; ethanol; water for injections; hydrochloric acid; sodium hydroxide; sodium acetate; glacial acetic acid - supraventricular tachycardia - for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. esmolol is also indicated in non-compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. esmolol is not intended for use in chronic settings where transfer to another agent is anticipated, or for treatment periods greater than 24 hours duration.
phebra calcium gluconate 953mg/10ml injection vial
phebra pty ltd - calcium gluconate monohydrate, quantity: 95.3 mg/ml - injection, solution - excipient ingredients: calcium saccharate; water for injections - calcium gluconate is a calcium salt used primarily for the prevention and treatment of calcium deficiency. parenteral administation of calcium gluconate is needed in acute hypocalcaemia and hypocalcsemic tetany. it can be given intravenously in the treatment of severe hyper-kalaemia and in overdosage of magnesium sulphate, as calcium is the antagonist of magnesium toxicity. iv injections have been used in the treatment of acute renal biliary and intestinal colic. calcium has been used as an inotrope in cardiac resuscitation. they may also be used for the prevention of hypocalcaemia in exchange transfusions, and in long term electrolyte replacement therapy.